Mbx Biosciences

Developer of drugs for the treatment of rare endocrine diseases

placeCarmel, Indiana, United States calendar_todayFounded 2018 groups11 employees language mbxbio.com

Registered entities

Innovation

1 patent family — focus: Human necessities; filing pace active. Cited 26 times.

YearFilings
20251

Social engagement

Social engagement: 11.3K social following, 10 posts in the last 12 months — around the industry typical range.

Investor mix

11 investors on record; lead investors include Deep Track Capital, Wellington, Frazier Healthcare Partners, IU Ventures; 2 have since exited.

Investor typeCountShare
Venture capital764%
Private equity19%
Other / undisclosed327%

Hiring activity

Hires occasionally

1 role tracked across 1 of the last 12 months

9 Mar 2026 · Clinical Trial Manager · Boston

22 May 2025 · Vice President, Chemistry · Carmel

6 Dec 2024 · Director of Analytical Chemistry · Carmel

Based on job postings tracked across public sources.

Recent activity

22 Jun 2026
Milestone
anniversary
12 Jun 2026
Event
Webcast of the conference call
1 Jun 2026
Event
Investor Webcast and conference call at 8:00 am ET on ENDO 2026
Coming soon